Compare ABEO & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABEO | WEYS |
|---|---|---|
| Founded | 1974 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.0M | 280.9M |
| IPO Year | 1980 | N/A |
| Metric | ABEO | WEYS |
|---|---|---|
| Price | $5.06 | $33.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $18.20 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 21.0K |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 3.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.29 | ★ 2.54 |
| Revenue | $400,000.00 | ★ $279,843,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,590.36 | N/A |
| P/E Ratio | ★ $4.17 | $12.98 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.93 | $25.51 |
| 52 Week High | $7.54 | $38.24 |
| Indicator | ABEO | WEYS |
|---|---|---|
| Relative Strength Index (RSI) | 52.04 | 64.56 |
| Support Level | $4.53 | $30.33 |
| Resistance Level | $5.61 | $34.15 |
| Average True Range (ATR) | 0.27 | 1.14 |
| MACD | 0.08 | 0.36 |
| Stochastic Oscillator | 49.30 | 90.29 |
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.